MDA Funds 'Omics for Neuromuscular Disease Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – As part of a new $13.7 million funding round, the Muscular Dystrophy Association has awarded grants to several research groups that will use genomics and genetics-based science to investigate the molecular causes of neuromuscular diseases.

The new funding will support a total of 40 researchers studying Duchenne muscular dystrophy (DMD), ALS/Lou Gehrig's disease, muscular atrophy, facioscapulohumeral muscular dystrophy, and links between diabetes and Freidreich's ataxia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.